Evidence map›Paper›PMID 11484058›Full record

ArticleNature2001

The DNA replication checkpoint response stabilizes stalled replication forks.

M Lopes, C Cotta-Ramusino, A Pellicioli, G Liberi, P Plevani, M Muzi-Falconi, C S Newlon, M Foiani

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 423 papers.

0numbers the graph read from it
0cells of the map it votes in
423citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

423 citing papers in PubMed, 737 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Revised mechanism of hydroxyurea-induced cell cycle arrest and an improved alternative.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Article
  17. Dysfunction of Gpl1-Gih35-Wdr83 Complex inInternational journal of molecular sciences · 2024
    Article
  18. Article
  19. Article
  20. Review

363 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

M LopesIstituto F.I.R.C. di Oncologia Molecolare, Via Serio 21, 20141, Milano, Italy.
C Cotta-Ramusino
A Pellicioli
G Liberi
P Plevani
M Muzi-Falconi
C S Newlon
M Foiani
University of Milan · ITRutgers, The State University of New Jersey · US

Funding

Telethon E.1108
6 · The paper itself

Abstract

In response to DNA damage and blocks to replication, eukaryotes activate the checkpoint pathways that prevent genomic instability and cancer by coordinating cell cycle progression with DNA repair. In budding yeast, the checkpoint response requires the Mec1-dependent activation of the Rad53 protein kinase. Active Rad53 slows DNA synthesis when DNA is damaged and prevents firing of late origins of replication. Further, rad53 mutants are unable to recover from a replication block. Mec1 and Rad53 also modulate the phosphorylation state of different DNA replication and repair enzymes. Little is known of the mechanisms by which checkpoint pathways interact with the replication apparatus when DNA is damaged or replication blocked. We used the two-dimensional gel technique to examine replication intermediates in response to hydroxyurea-induced replication blocks. Here we show that hydroxyurea-treated rad53 mutants accumulate unusual DNA structures at replication forks. The persistence of these abnormal molecules during recovery from the hydroxyurea block correlates with the inability to dephosphorylate Rad53. Further, Rad53 is required to properly maintain stable replication forks during the block. We propose that Rad53 prevents collapse of the fork when replication pauses.

Indexed as

Cell Cycle ProteinsDNA ReplicationSaccharomyces cerevisiae ProteinsCell CycleCheckpoint Kinase 2DNA, FungalEnzyme InhibitorsHydroxyureaMutationNucleic Acid ConformationNucleic Acid Synthesis InhibitorsPhosphorylationProtein Serine-Threonine KinasesReplication OriginRibonucleotide ReductasesSaccharomycetalesCell Cycle ProteinsCheckpoint Kinase 2DNA, FungalEnzyme InhibitorsHydroxyureaNucleic Acid Synthesis InhibitorsProtein Serine-Threonine KinasesRAD53 protein, S cerevisiaeRibonucleotide ReductasesSaccharomyces cerevisiae Proteins

Identifiers

PMID11484058
OpenAlexW2116468279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.